Effect of sumac powder on type 2 diabetes
- Conditions
- Type 2 Diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2014050410826N9
- Lead Sponsor
- Research Council of Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
individuals between 30 and 60 years of their diabetes diagnosed diabetes center and at least 3 years of getting passed; lack of disorders and diseases of the liver and biliary and renal disorders; no professional athletes; not taking antioxidant supplements, selenium, zinc, beta carotene, omega-3 and at least 3 months before the study began; no alcohol; the willingness of patients to participate in the study; refusing to participate in other research projects; no change in dose or type of medication; do not use insulin. Exclusion criteria: those who consume less than 80 percent were crushed packages; people who have changed the type and dose of your medication; the patient's unwillingness to continue the study; start taking any antioxidant supplement; recent receiving insulin; to become pregnant during the study; diseases of liver and biliary and renal dysfunction during the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: Glucose oxidase method.;Glycosylated hemoglobin. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: Spectrophotometric.;Insulin. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: IRMA.;Insulin Resistance. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: (glucose × insulin)/22.5.;Blood sugar levels two hours after a meal. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: Glucose oxidase method.;Beta-cell function. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: The amount of beta-cell function=(Fasting insulin × 20) / (fasting glucose, -3.5).
- Secondary Outcome Measures
Name Time Method Added at 2016-11-29: HS-CRP. Timepoint: Added at 2016-11-29: At the beginning and the end of study period. Method of measurement: Added at 2016-11-29: 10 ml blood sample.